 CSJJ- sto ck is set to go c razy on Mon day after annou ncement  on Friday 943 SUPER st ock pick for you on Monday - - OUR  last st ock pick AMUC is up 300 for the last 10 days from 1 to 3 CSJJ - CSJJ in Nego tiations to Acquire 35 in BioMedicom Inc - st ock  is set to go crazy on Monday after the announcement on Friday CSJJ - This is st ock GEM its a great buy below 10-14 cents and huge  pro fits could be made with CSJJ because it is lower priced stock so it can go up not only a few  per cent but a few hundred or thousand BREAKING NEWS - JUMP ON-BOARD TODAY HUGE PRO FITS EXPECTED CSJJ in Nego tiations to Acquire 35 in BioMedicom Inc Congratula tions to all members who took advantage of our last pick AMUC - The stock was profiled at 1 and hit 3 20 We believe that the SPEC ULATIVE NEAR TERM TARGET PRICE for next 3 days  - 0 11 We believe that the SPECU-LATIVE NEAR TERM TARGET PRICE for next 5 days  - 0 17  CSJJ CSJJ CSJJ CSJJ CSJJ   Trading Alert Coastal Holdings Inc Symbol SCJJ Current Price 0 021 We believe that the SPECULATIVE NEAR TERM TARGET PRICE for next 3 days -  0 11 We believe that the SPECULATIVE NEAR TERM TARGET PRICE for next 5 days -  0 15 NEWS- NEWS NEWS NEWS -NEWS ---------------------------------------------------------------- Coastal Holdings Inc in Negotiations to Acquire Interest in BioMedicom  Inc ---------------------------------------------------------------- HOUSTON Jun 25 2004 PRIMEZONE via COMTEX -- Coastal Holdings Inc  Pink Sheets CSJJ is pleased to announce that it is in negotiations to  acquire a 35 -45 equity interest in BioMedicom Inc BIOMED BIOMED  will be an exhibitor at the International Congress of Radiology to be  held June 27-29 2004 at the Palais des Congres de Montreal CSJJ CEO  Andrea Cortellazzi will be in negotiations with BIOMED CEO Michael  Berman prior to the start of the Congress in Montreal CSJJ will  announce the outcome of this meeting at a future date The investment in  BIOMED will be for a total of 2M with an initial deposit of 300 000  upon contract signing As part of the investment CSJJ would receive  distribution rights in North America to SONOReal a revolutionary add-on  to any ultrasound system This product makes 3D ultrasound imaging easy  to learn use and afford It increases the productive life of an  existing ultrasound system enabling 3D visualization in real-time  while maintaining familiar protocols SONOReal has received several  regulatory clearances notably from the ISO and the FDA About BioMedicom Inc BIOMED --------------- Disclaimer --------------- Information within this email contains forward looking  statements within the meaning of Section 27A of the Securities Act  of 1933 and Section 21B of the Securities Exchange Act of 1934 Any  statements that express or involve discussions with respect to  predictions goals expectations beliefs plans projections  objectives assumptions or future events or performance are not  statements of historical fact and may be forward looking  statements Forward looking statements are based on expectations estimates and  projections at the time the statements are made that involve a number of  risks and uncertainties which could cause actual results or events to  differ materially from those presently anticipated Forward looking  statements in this action may be identified through the use of words  such as projects foresee expects  estimates believes understands  will part of anticipates or that by  statements indicating certain actions may  could or might occur All information provided  within this email pertaining to investing stocks securities must be  understood as information provided and not investment advice we advise  all readers and subscribers to seek advice from a registered  professional securities representative before deciding to trade in  stocks featured within this email None of the material within this  report shall be construed as any kind of investment advice Please have  in mind that the interpretation of the witer of this newsletter about  the news published by the company does not represent the company  official statement and in fact may differ from the real meaning of what  the news release meant to say Please read the news release by yourself  and judge by yourself about the details in it In compliance with Section 17 b we disclose the holding of CRHI shares  prior to the publication of this report Be aware of an inherent  conflict of interest resulting from such holdings due to our intent to  profit from the liquidation of these shares Shares may be sold at any  time even after positive statements have been made regarding the above  company Since we own shares there is an inherent conflict of interest  in our statements and opinions Readers of this publication are  cautioned not to place undue reliance on forward-looking statements  which are based on certain assumptions and expectations involving  various risks and uncertainties that could cause results to differ  materially from those set forth in the forward- looking statements Please be advised that nothing within this email shall constitute a  solicitation or an offer to buy or sell any security mentioned herein  This newsletter is neither a registered investment advisor nor  affiliated with any broker or dealer All statements made are our  express opinion only and should be treated as such We may own buy and  sell any securities mentioned at any time This report includes  forward-looking statements within the meaning of The Private Securities  Litigation Reform Act of 1995 These statements may include terms as  expect believe may  will move undervalued and  intend or similar terms This newsletter was paid 16500  from third party to send this report PLEASE DO YOUR OWN DUE DILIGENCE  BEFORE INVESTING IN ANY PROFILED COMPANY You may lose money from  investing in Penny Stocks 